Our findings
deserve the following conclusions. 1) With an initial dose of 0.1 to 0.15 mg/kg, sufficient and excellent muscular relaxation for endotracheal intubation can be obtained within 2 -5 minutes after intravenous administration of pancuronium bromide in man. 2) A large dose of 3 mg/kg in total was used to maintain controlled respiration under moderate hypothermia to treat a 6 year-old boy who had general convulsion and muscular twitching which accidentally occurred postoperatively after open heart surgery for ASD. In reference to this case, we noted none of the untoward reactions like tachyphylaxis or cumulative action and none of the untoward responses in the cardiovascular system. 3) We did not experience the prolonged apnea which lasted more than two hours although a relatively large dose of pancuronium bromide had been used. Table 4 . Among these cases, one patient who underwent esophagoplasty had sufficient muscular relaxation with an initial dose of 0.15 mg/kg which lasted about 7 hours under a slight degree of hyperventilation. He was 68 years old and anemic, but complications like renal or hepatic dysfunction were not noted preoperatively. However, the prolonged neuromuscular block was promptly reversed by 1 mg of neostigmine and 0.5 mg of atropine at the end of the operation which lasted seven and half hours.
The total doses of the pancuronium bromide calculated on the basis of mg. per kilogram of body weight per hour of duration of surgery as shown in Table  3 ranged from 0.06 to 0.38 with an average of 0.17 mg/kg/hr.
About 25 % of our total cases were given more than 0. 1 mg/kg/hr.
In one particular case, a 6 recovery from apnea with or without neostigmine is shown in Fig. 2 . We recognized that the reversal of neuromuscular block was complete within 2 hours even with a large dose.
The interval (minutes) between the initial and the second injection of pancuronium bromide in relation to the site of cancer and the preoperative complications is shown in Table 5 . The transverse column on the left shows the various sites of cancer and the longitudinal column on the top their preopera- tive complications. The number in each column indicates the complete recovery time from the end of operation and a number of cases was put in parentheses. Seven cases with prolonged neuromus cular block which lasted for more than 2 hours with sufficient muscular relaxa tion were found among the 37 patients with cancer.
The highest incidence of prolonged block was noted in the anemic group with oesophageal, uterine and pulmonary cancer. Table 6 also shows the time interval between the initial and the second in jection of pancuronium bromide in re lation to the site of the malignant tumor except cancer and the preopera tive complications.
We experienced a prolonged neuromuscular block with 0.15 mg/kg of pancuronium in a 69 year-old anemic patient who underwent radical neck dissection for sarcoma of the neck. Table 7 shows the five cardiac pati ents with the same relationship as the tumor patients.
We did not experience the prolonged apnea which lasted more than two hours.
The relationship bet ween the other preoperative diseases and complications are shown in Table 8 . The five cases of prolonged block which lasted more than two hours were found. Of these, the three cases were accom panied by preoperative complications such as anemia, renal dysfunction and abnormal findings of E. K. G. ; but the two other cases presented no preopera tive complications.
The circulatory effect of pancuro nium bromide is very slight as shown in Fig. 3 . A steady rise of the pressure of radial artery without any change in central venous pressure on administra tion of pancuronium bromide 0.15 mg/kg was noted in the 68 year-old patient who underwent Whipple's operation under halothane and nitrous-oxide anesthesia. As shown in Fig. 4, a 16 thesia (2 mg/kg of Ketamine was given intravenously).
However, in this case, prior to a very slight rise in blood pressure, a transient and very slight fall was noted immediately after an administration of pancuronium bromide (0.15 mg/kg).
Fundamental investigation
To investigate the mechanism of hypertensive response which is slight, but steady even under halothane anesthesia, dogs weighing 11 to 15 kg were used. Fig. 5 shows from above, the recordings of E. K. G., aortic pressure, dp/dt of the aortic pressure, CVP, dp/dt of aortic flow rate (AFR), dp/dt of AFR, and circumference of the atria.
The measurement of the atrial circumference was made with use of a modified Whitney's mercury-in-silastic tube gauge which was fixed around the atria just beneath both auricles with fine sutures.
On administration of 0.3 mg/kg of pancuronium under 1.0 % of halothane and 50 % of nitrous oxide anesthesia, a steady rise in aortic pressure, decrease in the amplitude of dp/dt of aortic pressure were noted. E. K. G. and pulse rate did not show any changes. These cardiovascular effects due to administration of pancuronium would imply an anti-depressant effect to the circulatory changes due to halothane anesthesia. 
DISCUSSION

